Introducing Genomics in Healthcare and AB’s Insight into the Sector

Presented by

Ed Bryan, Research Analyst—Equities and Joanne M. Hackett, Previously Chief Commercial Officer at Genomics England

About this talk

The time for talking about the potential of genomic medicine is past. Genomics is not tomorrow. It’s here today. Genomics will transform patient outcomes and healthcare systems – and Genomics England is already moving to make a mainstream genomics medicine service a reality in the UK. Please join us to discover what Genomics England are doing and how AllianceBernstein is looking at Genomics and personalized healthcare as part of our investment universe and how these companies are helping the world achieve the UN Sustainable Goals.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (108)
Subscribers (6580)
AB provides forward-looking perspective, independent research and investment discipline across asset classes, from equities and fixed income to alternatives and multi-asset portfolios.